DUBLIN, Dec 19, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Influenza Vaccines Market in Top 5 European Countries to 2022 - Market Size, Development and Forecasts" report to their offering.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into influenza vaccine sales forecast for the top five countries, comprising the UK, France, Italy, Spain and Germany until 2022.
Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against Influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries.
Prudent analysis has been done on the competitor's part, where three major players grab major share of the influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the influenza vaccine market.
Other emerging players such as Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.
It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.
The report concludes with the profiles of major players in the influenza vaccine market, such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of influenza vaccine market.
Major and Promising Vaccines covered in the report are as follows:
1. Fluzone High-Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
13. TAK - 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
Key Companies Covered in the Report are as follows:
1. Sanofi Pasteur
5. Protein Sciences Corporation
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
Key Topics Covered:
1. Executive Summary
2. Influenza Vaccine Market in Top 5 European Countries - Market Overview
3. Influenza Vaccine Market Drivers and Barriers
4. Influenza Vaccine Market in Top 5 European Countries - Geographical Landscape
5. European Union Influenza Vaccine Market - Regulatory Landscape
6. Market Dynamics - Mergers, Acquisitions, Key Agreements & Collaborations
7. Influenza Vaccine - Pipeline Assessment
8. Influenza Vaccine - Clinical Trials Assessment by Phase and Trial Status
9. Key Companies Analysis
For more information about this report visit http://www.researchandmarkets.com/research/hcj3f7/influenza
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/top-5-european-influenza-vaccines-market-2016-2022-market-size-development-and-forecasts---market-is-expected-to-reach-more-than-us-1-billion-across-the-5-major-markets---research-and-markets-300379817.html
SOURCE Research and Markets